Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker ▴	Company	Revenue	Net income	Net margin	Return on equity	Revenue growth	Diluted EPS
CLRB	Cellectar Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$21.79M	n/a	-255.2%	n/a	-$8.35
CLYM	Climb Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$59.85M	n/a	-37.3%	n/a	-$0.88
CMMB	Chemomab Therapeutics Ltd. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$8.99M	n/a	-72.9%	n/a	$0.018
CMPS	COMPASS Pathways plc Manufacturing · Year ended 2025-12-31 · USD	n/a	-$287.86M	n/a	n/a	n/a	-$3.08
CNBX	CNBX Pharmaceuticals Inc. Manufacturing · Year ended 2025-08-31 · USD	$0	-$314.0K	n/a	n/a	-100.0%	$0.00
CNSP	CNS Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$15.85M	n/a	-350.5%	n/a	-$35.75
CNTB	Connect Biopharma Holdings Ltd Manufacturing · Year ended 2025-12-31 · USD	$64.0K	-$55.48M	n/m	-132.2%	-99.8%	-$1.00
CNTX	Context Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$36.12M	n/a	-59.7%	n/a	-$0.38
COCP	Cocrystal Pharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$8.83M	n/a	-139.5%	n/a	-$0.78
COGT	Cogent Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$328.94M	n/a	-51.7%	n/a	-$2.16
COLL	Collegium Pharmaceutical, Inc Manufacturing · Year ended 2025-12-31 · USD	$780.57M	$62.87M	8.1%	20.8%	23.6%	$1.73
CORT	Corcept Therapeutics Inc Manufacturing · Year ended 2025-12-31 · USD	$761.41M	$99.65M	13.1%	15.4%	12.8%	$0.82
COYA	Coya Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$7.95M	-$21.23M	-267.1%	-49.3%	123.6%	-$1.27
CPHI	China Pharma Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	$4.14M	-$3.19M	-76.9%	-14.0%	-8.5%	-$0.74
CPIX	Cumberland Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$44.52M	-$2.84M	-6.4%	-11.4%	17.6%	-$0.19
CPMD	Cannapharmarx, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.36M	-$11.13M	-817.2%	n/a	66.1%	-$0.02
CRBP	Corbus Pharmaceuticals Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$78.54M	n/a	-53.2%	n/a	-$5.90
CRMD	CorMedix Inc. Manufacturing · Year ended 2025-12-31 · USD	$311.71M	$163.06M	52.3%	40.2%	617.0%	$2.04
CRVO	CervoMed Inc. Manufacturing · Year ended 2025-12-31 · USD	$4.01M	-$26.97M	-673.1%	-148.0%	-58.9%	n/a
CRVS	Corvus Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$15.28M	n/a	-25.0%	n/a	-$0.53
CTMX	CytomX Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$76.20M	-$17.37M	-22.8%	-17.5%	-44.8%	n/a
CTNM	Contineum Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$59.98M	n/a	-23.0%	n/a	-$2.17
CTOR	Citius Oncology, Inc. Manufacturing · Year ended 2025-09-30 · USD	n/a	-$24.76M	n/a	-55.2%	n/a	-$0.34
CTXR	Citius Pharmaceuticals, Inc. Manufacturing · Year ended 2025-09-30 · USD	n/a	-$39.74M	n/a	-58.8%	n/a	-$3.38
CUE	Cue Biopharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	$27.47M	-$26.60M	-96.9%	-100.6%	195.7%	-$0.28

Rows per page: 2550 100